Application Information

This drug has been submitted to the FDA under the reference 022563/001.

Names and composition

"SORILUX" is the commercial name of a drug composed of CALCIPOTRIENE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
022563/001 SORILUX CALCIPOTRIENE AEROSOL, FOAM/TOPICAL 0.005%

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
020273/001 DOVONEX CALCIPOTRIENE OINTMENT/TOPICAL 0.005% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
020554/001 DOVONEX CALCIPOTRIENE CREAM/TOPICAL 0.005%
020611/001 DOVONEX CALCIPOTRIENE SOLUTION/TOPICAL 0.005% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
022563/001 SORILUX CALCIPOTRIENE AEROSOL, FOAM/TOPICAL 0.005%
077029/001 CALCIPOTRIENE CALCIPOTRIENE SOLUTION/TOPICAL 0.005%
077579/001 CALCIPOTRIENE CALCIPOTRIENE SOLUTION/TOPICAL 0.005%
078305/001 CALCIPOTRIENE CALCIPOTRIENE SOLUTION/TOPICAL 0.005%
078468/001 CALCIPOTRIENE CALCIPOTRIENE SOLUTION/TOPICAL 0.005%
090633/001 CALCIPOTRIENE CALCIPOTRIENE OINTMENT/TOPICAL 0.005%
200935/001 CALCIPOTRIENE CALCIPOTRIENE CREAM/TOPICAL 0.005%
205772/001 CALCIPOTRIENE CALCIPOTRIENE CREAM/TOPICAL 0.005%

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved